-
1 Comment
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Synaptogenix, Inc gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Exchange | BATS |
| CurrencyCode | USD |
| ISIN | US87167T2015 |
| Industry | Biotechnology |
| Market Cap | 11M |
|---|---|
| Target Price | 14 |
| PE Ratio | None |
| Beta | 0.0 |
| Dividend Yield | None |
Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of SNPS. This may include SNPS stock in addition to financial instruments. The fund is non-diversified.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SNPX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026